Counselors in Cottonwood, ID Accepting Medicare
3 Counselors found. Showing 1 - 3
 Ms. Bernadette Jamie Rundhaug, MED Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 701 Lewiston St, Cottonwood, ID 83522 Phone: 208-962-3251 |
 Mr. Dean E Allen, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 701 Lewiston St., Orr Building, Cottonwood, ID 83522 Phone: 208-790-4418 |
Bryan Leon Gimmeson, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 236 Radar Rd, Cottonwood, ID 83522 Phone: 208-962-3276 |
News Archive
Roche implements risk mitigation plan in taspoglutide Phase III programme
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
Risk for schizophrenia and bipolar disorder has distinct effects on the brain
Brain abnormalities in people at familial risk of schizophrenia and bipolar disorder emerge in unique patterns, despite the symptom and genetic overlap of the disorders, according to a study in Biological Psychiatry, published by Elsevier.
FDA approves Abstral drug for treatment of breakthrough pain in cancer patients
Orexo AB announces today that its partner ProStrakan Group plc has received approval from the US Food and Drug Administration for Abstral. Abstral is licensed for the treatment of breakthrough pain in cancer patients, 18 years of age and older, who are already receiving, and are tolerant to, opioid analgesics for their underlying persistent cancer pain.
3-D imaging of fibroblastic foci may help researchers study disease progression in IPF patients
Idiopathic pulmonary fibrosis (IPF) is a fatal disease in which progressive scarring of the lungs leads to respiratory failure. Lung scarring in IPF takes the form of aggregates of proliferating fibroblasts and myofibroblasts, known as "fibroblastic foci", which deposit collagen and other fibrotic components. These foci are thought to form in response to lung injury.
› Verified 3 days ago